Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Spencer Durham can be reached at 765-454-8598, by email at [email protected] or on Twitter at @Durham_KT.

Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor ...

The drugs became so popular so fast that manufacturers began running out, and patients scrambled to find Ozempic or Wegovy ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

The Name of the Year for 2024, according to the American Name Society, is “Ozempic," as in “Ozempic face,” “oat-zempic” and ...

Semaglutide is sold under the brand name Ozempic for type 2 diabetes treatment and Wegovy as a weight loss jab. It took reporters just ten minutes to find a seller willing to provide the drug without ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...